Live Breaking News & Updates on Christophe Hennequin

Stay updated with breaking news from Christophe hennequin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Long-Term, High-Dose Radiation, ADT Boosts Survival in Prostate Cancer

Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose.
....

France General , Christophe Hennequin , Department Of Radiation Oncology , Radiation Oncology , Saint Louis Hospital , Prostate Cancer ,

Higher-Dose RT Extends Survival in High-Risk Prostate Cancer

Adding higher dose radiation led to long-term ADT led to better progression-free, cancer-specific, and overall survival vs standard-dose radiation in men with high-risk prostate cancer. ....

United States , France General , Neha Vapiwala , Christophe Hennequin , American Society For Clinical Oncology , Radiation Therapy , Treating Patients Receiving Hormone Therapy , Prostate Cancer , Clinical Oncology , Genitourinary Cancers , Hospital Saint Louis , Penn Medicine , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Of The Prostate , Alignant Neoplasia , Alignant Neoplasm , Etastatic Carcinoma , Metastatic Cancer , Biologic Therapy , Prostate Specific Antigen , Sa Prostate Specific Antigen , Lymph Nodes ,

Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer

OS, PFS, cancer-specific survival all improved, with no increase in toxicity ....

France General , United States , Charles Bankhead , Neha Vapiwala , Christophe Hennequin , Tumor Group , Saint Louis Hospital , Genitourinary Cancers , French Genito Urinary Tumor Group , Penn Medicine , Androgen Deprivation Therapy , Medpage Today ,

Long-Term ADT Plus High-Dose Radiation Provides Survival Advantage in High-Risk Prostate Cancer

Long-term androgen deprivation therapy plus radiation therapy led to survival benefits without increased toxicity in high-risk prostate cancer. ....

France General , Christophe Hennequin , Department Of Radiation Oncology , Radiation Oncology , Saint Louis Hospital , Long Term Adt Plus 80 Gy Of Radiation Therapy , Patients With High Risk Prostate Cancer , Getug Afu 18 Trial ,